Skip to Main Content
HBS Home
  • About
  • Academic Programs
  • Alumni
  • Faculty & Research
  • Baker Library
  • Giving
  • Harvard Business Review
  • Initiatives
  • News
  • Recruit
  • Map / Directions
Faculty & Research
  • Faculty
  • Research
  • Featured Topics
  • Academic Units
  • …→
  • Harvard Business School→
  • Faculty & Research→
Publications
Publications
  • 2021
  • Working Paper
  • HBS Working Paper Series

Accounting for Product Impact in the Pharmaceuticals Industry

By: Amanda Rischbieth, George Serafeim and Katie Trinh
  • Format:Print
  • | Language:English
ShareBar

Abstract

We apply the product impact measurement framework of the Impact-Weighted Accounts Initiative (IWAI) in two competitor companies within the pharmaceuticals industry. We design a monetization methodology that allows us to calculate monetary impact estimates of accessible product provision and efficacy, among other factors. Our results indicate substantial differences in the impact that competitors have through their products. These differences demonstrate how impact reflects corporate strategy and informs decision-making on industry-specific areas.

Keywords

Product Innovation; Impact; Impact Investing; Impact Measurement; ESG; ESG (Environmental, Social, Governance) Performance; ESG Ratings; Social Corporate Responsibility; Corporate Social Responsibility; Social Impact; Pharmaceutical Companies; Pharmaceuticals; IWAI; Product Design; Product Positioning; Society; Environmental Sustainability; Corporate Social Responsibility and Impact; Product; Safety; Pharmaceutical Industry

Citation

Rischbieth, Amanda, George Serafeim, and Katie Trinh. "Accounting for Product Impact in the Pharmaceuticals Industry." Harvard Business School Working Paper, No. 21-139, June 2021.
  • SSRN
  • Read Now

About The Author

George Serafeim

Accounting and Management
→More Publications

More from the Authors

    • July 2023
    • Faculty Research

    Vytal: Packaging-as-a-Service

    By: George Serafeim, Michael W. Toffel, Lena Duchene and Daniela Beyersdorfer
    • June 2023
    • Faculty Research

    Roche: ESG and Access to Healthcare

    By: George Serafeim
    • June 2023
    • Faculty Research

    Investing in the Climate Transition at Neuberger Berman

    By: George Serafeim and Benjamin Maletta
More from the Authors
  • Vytal: Packaging-as-a-Service By: George Serafeim, Michael W. Toffel, Lena Duchene and Daniela Beyersdorfer
  • Roche: ESG and Access to Healthcare By: George Serafeim
  • Investing in the Climate Transition at Neuberger Berman By: George Serafeim and Benjamin Maletta
ǁ
Campus Map
Harvard Business School
Soldiers Field
Boston, MA 02163
→Map & Directions
→More Contact Information
  • Make a Gift
  • Site Map
  • Jobs
  • Harvard University
  • Trademarks
  • Policies
  • Accessibility
  • Digital Accessibility
Copyright © President & Fellows of Harvard College